首页|西洋参-石菖蒲治疗糖尿病脑病的网络药理学研究及其抗炎机制实验验证

西洋参-石菖蒲治疗糖尿病脑病的网络药理学研究及其抗炎机制实验验证

扫码查看
目的 采用网络药理学结合分子对接技术预测西洋参-石菖蒲治疗糖尿病脑病的作用机制,并进行实验验证.方法 利用TCMSP数据库筛选西洋参、石菖蒲的活性成分和作用靶点;使用GeneCards和Disgenet收集糖尿病脑病相关靶基因;利用STRING数据库和Cytoscape 3.8.2软件构建PPI网络并进行可视化分析;使用Metascape平台进行GO功能和KEGG通路富集分析.通过分子对接验证活性成分与关键靶点的结合能力.将大鼠按随机数字表法分为空白组、模型组及西洋参-石菖蒲低剂量组(1.08 g/kg)、西洋参-石菖蒲高剂量组(2.16 g/kg)、二甲双胍组(0.18 g/kg).除空白组外,其余各组采用腹腔注射链脲佐菌素法建立大鼠糖尿病脑病模型,给予相应药物干预12周后,采用Western blot法检测大鼠脑皮质TNF-α、环氧合酶-2(PTGS2)蛋白表达.结果 筛选得到西洋参-石菖蒲活性成分26个,治疗糖尿病脑病靶点107个,主要有TNF、JUN、PTSG2等,主要富集于TNF信号通路、癌症通路等.分子对接结果显示,西洋参-石菖蒲主要活性成分与PTGS2和TNF-α具有较为稳定的结合活性.实验结果显示,与模型组比较,各给药组PTGS2、TNF-α表达降低(P<0.05或P<0.01).结论 西洋参-石菖蒲可作用于TNF、CASP3、JUN、STAT3、PTGS2等核心靶点,调控TNF等信号通路,抑制炎症反应以达到治疗糖尿病脑病的作用.
Network pharmacology analysis on Panacis Quinquefolii Radix-Acori Tatarinowii Rhizoma for diabetes encephalopathy and experimental verification of its anti-inflammatory mechanism
Objective To predict the mechanism of Panacis Quinquefolii Radix-Acori Tatarinowii Rhizoma(PQ-AT)in the treatment of diabetes encephalopathy(DE)using network pharmacology combined with molecular docking;To conduct experimental verification.Methods The active components and targets of PQ and AT were screened by TCMSP database.The GeneCards and Disgenet were used to collect DE related target genes.String database and Cytoscape software were used to structure PPI network and perform visualization analysis.The common targets were imported into Metascape platform for GO annotation and KEGG enrichment analysis.Molecular docking was used to verify the binding ability of active components to core targets.Rats were randomly divided into a blank group,a model group,and a low-dose group of PQ-AT(1.08 g/kg),a high-dose group of PQ-AT(2.16 g/kg),and a metformin group(0.18 g/kg)using a random number table.To establish the rat model of diabetes encephalopathy,intraperitoneal injection of streptozotocin was used in addition to the blank group.After a 12-week drug intervention,TNF-α and Cyclooxygenase-2(PTGS2)protein expression in the cerebral cortex of rats was detected using Western blot.Results A total of 26 active components in PQ-AT and 107 related targets of DE were obtained,mainly including TNF,JUN,and PTSG2,which were mainly concentrated in TNF signaling pathway,cancer and other signal pathways.Molecular docking showed that the main active components of PQ-AT had relatively stable binding activity with TNF-αand PTGS2.Western blot results shows that compared with the model group,the expressions of PTGS2 and TNF-α significantly decreased in each administration group(P<0.05 or P<0.01).Conclusion PQ-AT can act on TNF,CASP3,JUN,STAT3,PTGS2 and other core targets to regulate signal pathways such as TNF,and inhibit inflammatory reaction to achieve the effect of treating DE.

Panacis Quinquefolii RadixAcori Tatarinowii RhizomaDiabetic encephalopathyInflammationNetwork pharmacologyMolecular docking simulation

刘琳、张骄骄、王冬雪、康靖飞、王凯、杨洋

展开 >

哈尔滨商业大学药学院,哈尔滨 150076

西洋参 石菖蒲 糖尿病脑病 炎症 网络药理学 分子对接模拟

2024

国际中医中药杂志
中华医学会,中国中医科学院中医药信息研究所

国际中医中药杂志

CSTPCD
影响因子:0.411
ISSN:1673-4246
年,卷(期):2024.46(1)
  • 17